Combination | Baseline (n = 6,771) | 3 Months of Follow-up | 12 Months of Follow-up | ||||||
---|---|---|---|---|---|---|---|---|---|
CRP Training | Communication Training | CRP Training | Communication Training | ||||||
Control (n = 2,040) | Intervention (n = 2,224) | Control (n = 1,932) | Intervention (n = 2,332) | Control (n = 2,463) | Intervention (n = 2,699) | Control (n = 2,464) | Intervention (n = 2,698) | ||
Sex, female, No. (%) | 4,218 (62) | 1,311 (64) | 1,423 (64) | 1,223 (63) | 1,511 (65) | 1,470 (60) | 1,620 (60) | 1,466 (60) | 1,624 (60) |
Age, mean (SD), y | 49.6 (18.6) | 50.9 (17.3) | 51.0 (17.5) | 50.8 (17.6) | 51.1 (17.2) | 51.7 (18.8) | 51.2 (18.7) | 51.1 (18.6) | 51.7 (18.8) |
Never-smoker, No. (%) | N/A | 1,067 (52) | 1,147 (52) | 1,041 (54) | 1,173 (50) | N/A | N/A | N/A | N/A |
Illness duration before index consultation ≥5 days, No. (%) | 3,542 (53)a | 1,038 (51)a | 1,128 (51)a | 994 (52)a | 1,172 (51)a | 1,026 (42) | 1,198 (44) | 1,032 (42) | 1,192 (44) |
Respiratory rate ≥25 breaths/minute, No. (%) | N/A | 101 (5)a | 123 (6)a | 145 (8)a | 79 (3)a | 65 (3)a | 133 (5) | 96 (4) | 102 (4) |
Temperature ≥38°C, No. (%) | N/A | 228 (11)a | 280 (13)a | 202 (11)a | 306 (13)a | 291 (12) | 380 (14) | 285 (12) | 386 (14) |
CRP = C-reactive protein; N/A = not available.
↵a Data missing for some patients.